887 McKesson Corporation $MCK Shares Acquired by Ritholtz Wealth Management

Ritholtz Wealth Management raised its position in McKesson Corporation (NYSE:MCK) by 6.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,918 shares of the company’s stock after buying an additional 887 shares during the quarter. Ritholtz Wealth Management’s holdings in McKesson were worth $12,737,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in MCK. BlackRock Inc. bought a new stake in McKesson in the 2nd quarter valued at about $8,156,743,000. Bank of America Corp DE lifted its holdings in McKesson by 2.4% during the first quarter. Bank of America Corp DE now owns 1,538,726 shares of the company’s stock valued at $1,331,552,000 after purchasing an additional 35,916 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in McKesson by 3.3% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 922,573 shares of the company’s stock worth $697,096,000 after purchasing an additional 29,747 shares during the period. Legal & General Group Plc bought a new position in McKesson during the second quarter worth about $656,566,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of McKesson in the second quarter worth about $651,462,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Top McKesson Stories

Investors following MCK have been watching these stories:

• Positive Sentiment: McKesson reportedly raised its fiscal 2027 adjusted EPS outlook, a potential signal of confidence in future earnings. The article listing does not provide the revised forecast figures. McKesson stock raises fiscal 2027 adjusted EPS outlook
• Positive Sentiment: Zacks highlighted McKesson’s growth attributes as reasons investors may find the stock attractive. 3 Reasons Why Growth Investors Shouldn’t Overlook McKesson
• Neutral Sentiment: McKesson was a trending search on Zacks, indicating heightened investor attention, but the article listing does not identify a new business development behind that interest. Here is What to Know Beyond Why McKesson is a Trending Stock

Analysts Set New Price Targets

Several research firms have recently issued reports on MCK. Argus boosted their price target on shares of McKesson from $850.00 to $970.00 and gave the company a “buy” rating in a research report on Thursday, September 3rd. Robert W. Baird set a $1,015.00 price objective on shares of McKesson in a report on Thursday, August 6th. Citigroup lifted their price objective on shares of McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Mizuho boosted their target price on shares of McKesson from $905.00 to $1,020.00 and gave the company a “neutral” rating in a report on Tuesday, October 20th. Finally, Evercore reissued an “outperform” rating and set a $950.00 target price (down from $1,000.00) on shares of McKesson in a report on Thursday, August 6th. Fifteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and an average price target of $1,040.29.

McKesson Stock Performance

Shares of MCK opened at $1,080.76 on Thursday. McKesson Corporation has a 52-week low of $723.68 and a 52-week high of $1,121.50. The stock’s 50-day simple moving average is $948.83 and its 200 day simple moving average is $871.94. The stock has a market capitalization of $124.79 billion, a price-to-earnings ratio of 27.79, a price-to-earnings-growth ratio of 1.83 and a beta of 0.27.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. The business had revenue of $110.96 billion during the quarter, compared to analyst estimates of $109.90 billion. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. The company’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $9.86 EPS. On average, research analysts forecast that McKesson Corporation will post 46.16 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be given a $0.94 dividend. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Tuesday, December 1st. McKesson’s dividend payout ratio (DPR) is 9.67%.

Insider Buying and Selling

In related news, CAO B Jr sold 111 shares of the business’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the completion of the transaction, the chief accounting officer owned 521 shares of the company’s stock, valued at approximately $464,445.45. The trade was a 17.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Francisco Fraga sold 800 shares of the business’s stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the transaction, the executive vice president directly owned 5,423 shares of the company’s stock, valued at approximately $5,400,223.40. This represents a 12.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161 shares of company stock valued at $2,242,515 over the last 90 days. 0.06% of the stock is owned by company insiders.

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.